Literature DB >> 25352631

Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.

Dimitrios P Kontoyiannis1, Thomas F Patterson1.   

Abstract

In the last 5 years we have witnessed further developments in diagnosis and treatment of invasive fungal infections (IFIs) that complicate cancer chemotherapy. In this brief overview, we highlight some advancement, discuss future directions, and unmet needs in this complex area.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Aspergillosis; cancer; candidiasis; diagnosis; treatment

Mesh：

Substances：

Year:  2014        PMID： 25352631      PMCID： PMC4303053          DOI： 10.1093/cid/ciu591

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  34 in total

Review 1.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; J Peter Donnelly; Paul E Verweij
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

2.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

Review 3.  Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Authors:  Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack Sobel; Claudio Viscoli; Thomas J Walsh; Johan Maertens; Thomas F Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John R Graybill; Lindsey R Baden; Peter G Pappas; John E Bennett; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart-Jan Kullberg; William E Dismukes; Ben E De Pauw
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

4.  MALDI-TOF mass spectrometry identification of filamentous fungi in the clinical laboratory.

Authors:  Stéphane Ranque; Anne-Cécile Normand; Carole Cassagne; Jean-Benjamin Murat; Nathalie Bourgeois; Frédéric Dalle; Martine Gari-Toussaint; Patrick Fourquet; Marijke Hendrickx; Renaud Piarroux
Journal:  Mycoses       Date:  2013-07-29       Impact factor: 4.377

5.  The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections.

Authors:  Georgios Chamilos; Homer A Macapinlac; Dimitrios P Kontoyiannis
Journal:  Med Mycol       Date:  2008-02       Impact factor: 4.076

6.  Cyclophosphamide metabolism is affected by azole antifungals.

Authors:  Kieren A Marr; Wendy Leisenring; Fulvio Crippa; John T Slattery; Lawrence Corey; Michael Boeckh; George B McDonald
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

7.  Time to blood culture positivity as a marker for catheter-related candidemia.

Authors:  Ronen Ben-Ami; Miriam Weinberger; Ruth Orni-Wasserlauff; David Schwartz; Avraham Itzhaki; Tzipora Lazarovitch; Edna Bash; Yuval Aharoni; Irina Moroz; Michael Giladi
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

8.  Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study.

Authors:  Russell E Lewis; Lizebeth Cahyame-Zuniga; Konstantinos Leventakos; Georgios Chamilos; Ronen Ben-Ami; Pheroze Tamboli; Jeffrey Tarrand; Gerald P Bodey; Mario Luna; Dimitrios P Kontoyiannis
Journal:  Mycoses       Date:  2013-04-04       Impact factor: 4.377

9.  Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients.

Authors:  Johan Maertens; Kristel Buvé; Koen Theunissen; Wouter Meersseman; Eric Verbeken; Gregor Verhoef; Johan Van Eldere; Katrien Lagrou
Journal:  Cancer       Date:  2009-01-15       Impact factor: 6.860

10.  A risk prediction score for invasive mold disease in patients with hematological malignancies.

Authors:  Marta Stanzani; Russell E Lewis; Mauro Fiacchini; Paolo Ricci; Fabio Tumietto; Pierluigi Viale; Simone Ambretti; Michele Baccarani; Michele Cavo; Nicola Vianelli
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240
View more
  8 in total

1.  How I transplant a patient with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-08-26       Impact factor: 22.113

Review 2.  CMV Prevention and Treatment in Transplantation: What's New in 2019.

Authors:  Anat Stern; Genovefa A Papanicolaou
Journal:  Curr Infect Dis Rep       Date:  2019-11-15       Impact factor: 3.725

3.  How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard E Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

4.  Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.

Authors:  Georgios Chamilos; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

Review 5.  Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

Authors:  M Martino; R M Lemoli; C Girmenia; L Castagna; B Bruno; F Cavallo; M Offidani; I Scortechini; M Montanari; G Milone; L Postacchini; A Olivieri
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

6.  Management of Invasive Fungal Infections in Adult Patients with Hematological Malignancies in Greece during the Financial Crisis: Challenges and Recommendations.

Authors:  Nikolaos V Sipsas; Maria N Pagoni; Diamantis P Kofteridis; Joseph Meletiadis; Georgia Vrioni; Maria Papaioannou; Anastasia Antoniadou; George Petrikkos; George Samonis
Journal:  J Fungi (Basel)       Date:  2018-08-09

7.  Aspergillus endocarditis: Diagnostic criteria and predictors of outcome, A retrospective cohort study.

Authors:  Marwa Sayed Meshaal; Dina Labib; Karim Said; Mohammed Hosny; Mohammed Hassan; Said Abd Al Aziz; Amani Elkholy; Mervat Anani; Hussien Rizk
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

8.  Diagnostic Capacity for Invasive Fungal Infections in the Greek Paediatric Haematology-Oncology Units: Report from the Infection Working Group of the Hellenic Society of Paediatric Haematology-Oncology.

Authors:  Anthi-Marina Markantonatou; Athanasios Tragiannidis; Vasiliki Galani; Dimitrios Doganis; Kondilia Antoniadi; Haroula Tsipou; Maria Lambrou; Nikolaos Katzilakis; Anna Paisiou; Maria Palabougiouki; Marina Servitzoglou; Eugenia Papakonstantinou; Ioulia Peristeri; Efthichia Stiakaki; Eleni Kosmidis; Sophia Polychronopoulou; Antonios Kattamis; Timoleon-Achilleas Vyzantiadis
Journal:  J Fungi (Basel)       Date:  2021-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.